UK drugs giant AstraZeneca announces $15 bn investment in China
China is AstraZeneca's second-largest market after the United States, where the company has recently invested heavily under pressure from President Donald Trump.
Your blog category
China is AstraZeneca's second-largest market after the United States, where the company has recently invested heavily under pressure from President Donald Trump.
While the survey highlighted several policy measures taken by the government to address mental health challenges—such as the Tele-MANAS mental health helpline and restrictions on online gaming—it emphasized that “developing…
With India facing a rapid rise in cancer cases and mortality, a focused approach to treatment and interventions is critical. ETHealthWorld’s India Oncology Leader Summit will bring together leading clinicians,…
The data shared during high-level scientific deliberations underscores that mental illness in India is no longer confined to later stages of life but is increasingly affecting adolescents, young adults and…
The two-day conclave brought together national and international experts to deliberate on evidence-based, stigma-free and patient-centric approaches to obesity care.
This combined effect, the researchers say, may also help explain the occurrence of gastrointestinal infections in high-altitude areas. By quantitatively demonstrating how both horizontal dust transport and vertical lifting of…
The company said the expansion would bring its globally proven automation technologies closer to Indian healthcare providers, helping improve accuracy, traceability, medication safety and operational efficiency across hospital and pharmacy…
The emerging Free Trade Agreements (FTAs) present an important opportunity for India to secure smoother regulatory pathways, mutual recognition of standards, and faster market approvals—critical enablers for global competitiveness in…
Encouraging deeper investment in research-intensive segments and providing carefully designed fiscal support for research activity can nudge firms toward higher-value participation without distorting incentives.
The institute will cater to both paediatric and adult patients and is equipped to treat conditions such as leukaemia, lymphoma, multiple myeloma, aplastic anaemia, bone marrow failure syndromes, thalassemia and…